Call us: +202 22 905 906
E-Mail: mail@alpha-pharmaceuticals.com
You are here
National Institutes of Health (NIH)
Study identifies cardiovascular risk factors that may lead to pregnancy problems for first-time moms
NIH-supported findings also show cardiovascular risks and pregnancy complications can raise chances of hypertension years after childbirth .
The single-shot vaccine is the third COVID-19 vaccine in the United States to be granted an EUA.
Newly authorized COVID-19 diagnostic kit is paired with smartphone app.
Program to investigate why some children are at greater risk for SARS-CoV-2 infection than others.
Findings suggest that the pandemic may have impacted the availability and demand of some, but not all, illegal drugs.
Study shows the treatment is safe, but provides no significant benefit in this group.
Effort is part of the Accelerating Medicines Partnership to enable development of effective targeted therapies.
Finding could lead to new ways to reduce complications from painful red blood cell disorder.
ACTIV-3 is a master protocol designed to allow for the study of multiple investigational agents compared to placebo in adults hospitalized with COVID-19.
Trial explores the use of the Eliquis® in patients who have been discharged from the hospital following a diagnosis of moderate-to-severe COVID-19.